by Jessica Casebolt | Mar 14, 2023 | Payers, Tea Leaves
Thousands of patients have called on a federal court to reverse a landmark ruling allowing a UnitedHealth Group subsidiary to develop mental and substance abuse coverage guidelines they allege deviate from clinical standards. The American Medical Association, the...
by Jessica Casebolt | Mar 14, 2023 | Access & Coverage, Tea Leaves
The Veterans Health Administration (VHA) announced yesterday that it intends to pay for the experimental Alzheimer’s drug, Leqembi, that the Centers for Medicare and Medicaid Services has to date declined to cover. The decision by VHA stands in contrast with...
by Jessica Casebolt | Mar 13, 2023 | Life Sciences, Tea Leaves
Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation. A study published in the New England Journal of Medicine directly compared the three approaches of surgery to remove...
by Jessica Casebolt | Mar 13, 2023 | Inequities and SDOH, Tea Leaves
Despite a record-low infant mortality rate in 2020, a new study finds an unexpected jump in unexplained deaths in Black infants during the first year of the coronavirus pandemic. The rate of SIDS, or sudden infant death syndrome, increased by 15 percent in a single...
by Jessica Casebolt | Mar 13, 2023 | D.C. News, Tea Leaves
Assistant White House press secretary Kevin Munoz, who worked on messaging on the coronavirus pandemic and other health policy issues, is set to leave his post later this month. In his role, he worked on COVID-19 issues, from vaccinations and boosters to mask mandates...
by Jessica Casebolt | Mar 10, 2023 | Public Health/Prevention, Tea Leaves
The FDA is updating mammography guidelines in a move that could protect people at higher risk of developing breast cancer but also drive up demand for more tests and screenings. The agency’s new rule requires mammogram providers to notify patients about breast...
Recent Comments